MedTrace Logo

Drug Use-Results Survey on Picoprep® Combination Powder

NCT03631446 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1298

Last updated 2022-01-18

No results posted yet for this study

Summary

The purpose of this survey is to confirm safety and efficacy with patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

Conditions

  • Bowel Cleansing

Interventions

DRUG

Sodium Picosulfate, Magnesium Oxide and Citric Acid

Combination powder for oral solution

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Global Clinical Compliance · Ferring Pharmaceuticals

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-29
Primary Completion
2021-12-31
Completion
2021-12-31
FDA Drug
Yes

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03631446 on ClinicalTrials.gov